Dermatology Medical News about Vitiligo

Your Unread Messages

See All

Tracy Hampton, PhD

FDA Update

Anti-CD20 Antibody Granted Accelerated Approval for CLL

Roberta Buell, MBA
Congress Proposes SGR Fix

Dorothy J. Schirf, MD

Technology Advances

Radiosurgery Trial Sparks Optimism for Early Lung Cancer

Sara Hartley

Cancer Science

The Depressing Thing About Cancer

See All Messages (38 new messages)

Hello, Suzanne Dixon
Manage E-mail | Logout

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Doctors and the DEA Free full text

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Macrophage migration inhibitory factor in patients with vitiligo and relationship between duration and clinical type of disease
Clinical and Experimental Dermatology, 11/03/09

Serarslan G et al. – Mean serum MIF level of patients with vitiligo was higher than that of controls, indicating that MIF has a role in the pathogenesis of vitiligo.

<< Previous
The contribution of neurogenic inflammation to sensitive skin:...

Next >>
Specific repair of aging hair keratin

Today in Cosmetic Derm/Acne...keeping you current

Choosing the best treatments for acne
The Clinical Advisor, 11/03/09

Management of acne vulgaris: an evidence-based update
Clinical and Experimental Dermatology, 11/02/09

Alefacept for Severe Alopecia Areata
Archives of Dermatology, 11/17/09

See All of Cosmetic Derm/Acne

Today in Dermatopathology...keeping you current

Erysipeloid: a review
Clinical and Experimental Dermatology, 09/18/09

Update on oral lichen planus
Expert Review of Dermatology, 10/14/09

Childhood melanoma
Clinics in Dermatology, 11/04/09

See All of Dermatopathology

Sponsor

Article Search